FDA Inspection 1108380 — Monika Rudzinska-Bar, MD, PhD
The FDA completed an inspection of Monika Rudzinska-Bar, MD, PhD on October 11, 2019 in Cracow. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 11, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cracow (Poland)
Additional Details
Clinical Investigator (CI)